𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Simultaneous expression of nitric oxide synthase and estrogen receptor in human breast cancer cell lines

✍ Scribed by Robert Zeillinger; Eva Tantscher; Christian Schneeberger; Walter Tschugguel; Sabine Eder; Gerhard Sliutz; Johannes C. Huber

Publisher
Springer US
Year
1996
Tongue
English
Weight
241 KB
Volume
40
Category
Article
ISSN
0167-6806

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Impairment of stimulation by estrogen of
Impairment of stimulation by estrogen of insulin-activated nitric oxide synthase in human breast cancer
✍ Manti Guha; Jaydip Biswas; Jaya Tirkey; A. Kumar Sinha 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 115 KB

## Abstract Nitric oxide (NO) is reported to have several important effects in the control of neoplasm. We have reported before the presence of an insulin‐activated constitutive form of membrane‐bound nitric oxide synthase (IANOS) in various cells. Since the insulin‐induced NO synthesis by IANOS co

Phytoestrogens activate estrogen recepto
Phytoestrogens activate estrogen receptor β1 and estrogenic responses in human breast and bone cancer cell lines
✍ Brian G. Chrzan; Peter G. Bradford 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 398 KB

## Abstract Plant‐derived phytoestrogens and estrogens in hormone replacement therapies have overlapping yet sometimes divergent effects on the incidence of breast cancer and osteoporosis. Using human MCF‐7 breast carcinoma and G‐292 osteosarcoma cell lines, it was investigated whether the phytoest

Quercetin induces type-II estrogen-bindi
Quercetin induces type-II estrogen-binding sites in estrogen-receptor-negative (MDA-MB231) and estrogen-receptor-positive (MCF-7) human breast-cancer cell lines
✍ G. Scambia; S. Mancuso; P. Benedetti Panici; R. De Vincenzo; G. Ferrandina; G. B 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 French ⚖ 536 KB

## Abstract We show that flavonoids positively regulate type‐II estrogen‐binding site (type‐ll EBS) levels both in MCF‐7 (ER‐positive) and in MDA‐MB231 (ER‐negative) breast‐cancer cells. Type‐ll EBS were measured by a whole‐cell assay at 4°C for 2.5 hr using [^3^H]‐estradiol as tracer. In both cell